๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis

โœ Scribed by G Holmgren; L Steen; O Suhr; B.-G Ericzon; C.-G Groth; O Andersen; B.G Wallin; A Seymour; S Richardson; P.N Hawkins; M.B Pepys


Book ID
119067343
Publisher
The Lancet
Year
1993
Tongue
English
Weight
584 KB
Volume
341
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical symptomatic de novo systemic tr
โœ Ana Paula Barreiros; Christian Geber; Frank Birklein; Peter R. Galle; Gerd Otto ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 39 KB

Four years ago, Stangou et al. 1 reported a patient who developed clinical symptoms of amyloidosis 8 years after domino liver transplantation (DLT). In order to alleviate the graft shortage, livers from patients with familial amyloidotic polyneuropathy (FAP) are used as domino grafts for other pati

Poor outcome after liver transplantation
โœ Kate R. Muller; Robert Padbury; Gary P. Jeffrey; Nicola K. Poplawski; Philip Tho ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

Transthyretin amyloid polyneuropathy, caused by mutations in the transthyretin gene, is a progressive condition for which liver transplantation is an established treatment. Favorable outcomes have been described in patients with the most common transthyretin mutation, Val30Met, but outcomes have bee

Marked regression of abdominal fat amylo
โœ Ayako Tsuchiya; Masahide Yazaki; Fuyuki Kametani; Yo-ichi Takei; Shu-ichi Ikeda ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 504 KB

To elucidate whether the amount of tissue-deposited amyloid in familial amyloid polyneuropathy (FAP) patients decreases or increases over the long-term course after liver transplantation (LT), we examined changes in histopathological and biochemical characteristics of abdominal fat amyloid in the tr